GHRP-6 vs Hexarelin
A factual side-by-side from public databases — chemical identity, literature volume, and attributed independent-test coverage. Not a recommendation; we don't rank one above the other.
Growth hormone-releasing peptide 6 (GHRP-6) is a synthetic hexapeptide (also described as part of the GHRP class of GH secretagogues/peptidomimetics). Research reports include diagnostic testing of pituitary GH reserve, preclinical studies in models of organ injury, and development/validation of analytical methods for its measurement in biological matrices and transdermal formulations.
Hexarelin is described in the provided literature as a synthetic growth hormone (GH)-releasing peptide (growth hormone secretagogue) that can activate the growth hormone secretagogue receptor (GHSR) in the brain, and the provided review evidence also frames GH secretagogues as acting via pulsatile GH release subject to negative feedback.
| GHRP-6 | Hexarelin | |
|---|---|---|
| Family | Ghrelin / GH secretagogues | Ghrelin / GH secretagogues |
| Research goals | GH axis support | GH axis support |
| Amino acids | — | — |
| Molecular formula | C46H56N12O6 | C47H58N12O6 |
| Molecular weight | 873 g/mol | 887 g/mol |
| CAS number | — | 140703-51-1 |
| Approx. half-life | — | — |
| Regulatory status | Unknown | Unknown |
| WADA status | — | — |
| Evidence maturity | — | — |
| Research references | 9 | 8 |
| Vendors independently tested | 0 | 0 |
| Best test score (Finnrick) | — | — |